WFDC11 Plays A Crucial Role in Neural Tube Formation and Cancer Development
WFDC11 Plays A Crucial Role in Neural Tube Formation and Cancer Development
WFDC11 (WFD11_HUMAN) is a protein that is expressed in various tissues of the human body. It is a member of the Wnt signaling pathway, which is a well-established mechanism for the development and maintenance of tissues during embryonic development and throughout life. WFDC11 plays a crucial role in this pathway, as it is involved in the formation of the neural tube, which will eventually become the brain and spinal cord.
Recent studies have identified WFDC11 as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and developmental disorders. This has led to a great deal of interest in the research of WFDC11 and its potential applications in medicine.
The Wnt signaling pathway and its role in development and tissue formation
The Wnt signaling pathway is a highly conserved signaling pathway that is involved in the development and maintenance of various tissues during embryonic development and throughout life. It is characterized by the presence of the Wnt protein, which is a transmembrane glycoprotein that plays a central role in the pathway.
The Wnt pathway is involved in the formation of the neural tube, which is a structure that will eventually become the brain and spinal cord. During embryonic development, the neural tube forms from a pool of cells that have the ability to develop into different types of nervous tissue. The neural tube is formed by the action of the Wnt protein, which is expressed in high levels in the neural tube epithelium and is involved in the formation of the neural tube by promoting the migration of cells along the embryonic axis.
The role of WFDC11 in the neural tube formation
WFDC11 is a key protein that is involved in the formation of the neural tube during embryonic development. It is expressed in the neural tube epithelium and is involved in the formation of the neural tube by promoting the migration of cells along the embryonic axis.
Studies have shown that WFDC11 plays a crucial role in the neural tube formation by promoting the migration of cells along the embryonic axis. During embryonic development, WFDC11 is expressed in the neural tube epithelium and is involved in the formation of the neural tube by promoting the migration of cells along the embryonic axis.
The potential clinical applications of WFDC11 as a drug target or biomarker
The potential clinical applications of WFDC11 as a drug target or biomarker are vast and varied. One of the main applications is in the treatment of cancer, as WFDC11 has been shown to be involved in the development and progression of various types of cancer.
WFDC11 has also been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Studies have shown that WFDC11 is involved in the development of these diseases by promoting the formation of neurofibrillary tangles, which are thought to be a hallmark of neurodegenerative diseases.
In addition to its potential clinical applications, WFDC11 has also been shown to be a potential biomarker for various diseases. Studies have shown that WFDC11 is involved in the development and progression of cancer by promoting the formation of cancer cells, as well as by regulating the growth and differentiation of cancer cells.
The potential mechanisms by which WFDC11 promotes cancer development
WFDC11 is involved in the development and progression of cancer by promoting the formation of cancer cells and by regulating the growth and differentiation of cancer cells. This is accomplished through its role in the Wnt signaling pathway, which is a highly conserved signaling pathway that is involved in the development and maintenance of various tissues during embryonic development and throughout life.
The Wnt pathway is involved in the formation of the neural tube, which is a structure that will eventually become the brain and spinal cord. During embryonic development, the neural tube forms from a pool of cells that have the ability to develop into different types of nervous tissue. The neural tube is formed by the action of the
Protein Name: WAP Four-disulfide Core Domain 11
The "WFDC11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about WFDC11 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
WFDC12 | WFDC13 | WFDC2 | WFDC21P | WFDC3 | WFDC5 | WFDC6 | WFDC8 | WFDC9 | WFIKKN1 | WFIKKN2 | WFS1 | WHAMM | WHAMMP1 | WHAMMP2 | WHAMMP3 | WHRN | WIF1 | WIPF1 | WIPF2 | WIPF3 | WIPI1 | WIPI2 | WIZ | WLS | WNK1 | WNK2 | WNK3 | WNK4 | Wnt | WNT1 | WNT10A | WNT10B | WNT11 | WNT16 | WNT2 | WNT2B | WNT3 | WNT3A | WNT4 | WNT5A | WNT5B | WNT6 | WNT7A | WNT7B | WNT8A | WNT8B | WNT9A | WNT9B | WRAP53 | WRAP73 | WRN | WRNIP1 | WSB1 | WSB2 | WSCD1 | WSCD2 | WSPAR | WT1 | WT1-AS | WTAP | WTAPP1 | WTIP | WWC1 | WWC2 | WWC2-AS2 | WWC3 | WWOX | WWP1 | WWP2 | WWTR1 | WWTR1-AS1 | XAB2 | XACT | XAF1 | XAGE-4 | XAGE1A | XAGE1B | XAGE1D | XAGE2 | XAGE3 | XAGE5 | XBP1 | XCL1 | XCL2 | XCR1 | XDH | XG | XGY2 | XIAP | XIRP1 | XIRP2 | XIST | XK | XKR3 | XKR4 | XKR5 | XKR6 | XKR7 | XKR8
